Home LiteratureArticle Details
PMID: 11226285 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells.

Park BH, Vogelstein B, Kinzler KW

Abstract

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that have been implicated in a variety of biologic processes. The PPARdelta isotype was recently proposed as a downstream target of the adenomatous polyposis coli (APC)/beta-catenin pathway in colorectal carcinogenesis. To evaluate its role in tumorigenesis, a PPARdelta null cell line was created by targeted homologous recombination. When inoculated as xenografts in nude mice, PPARdelta -/- cells exhibited a decreased ability to form tumors compared with PPARdelta +/- and wild-type controls. These data suggest that suppression of PPARdelta expression contributes to the growth-inhibitory effects of the APC tumor suppressor.

MeSH Terms
Anti-Inflammatory Agents, Non-Steroidal/pharmacology Apoptosis/drug effects Base Sequence Cell Transformation, Neoplastic/genetics Colorectal Neoplasms/genetics,pathology DNA Primers Humans Receptors, Cytoplasmic and Nuclear/genetics,physiology Sulindac/pharmacology Transcription Factors/genetics,physiology Tumor Cells, Cultured
Chemicals
Anti-Inflammatory Agents, Non-Steroidal DNA Primers Receptors, Cytoplasmic and Nuclear Transcription Factors Sulindac
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Park B H
Johns Hopkins Oncology Center and Howard Hughes Medical Institute, 1650 Orleans Street, Room 590, Baltimore, MD 21231, USA.
Vogelstein B
Kinzler K W
References (27)
27 references, click to expand
  1. Peroxisome proliferator-activated receptors: insight into multiple cellular functions.
    Mutat Res. 2000 Mar 17;448(2):121-38 PMID: 10725467
  2. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.
    Cell. 1999 Oct 29;99(3):335-45 PMID: 10555149
  3. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).
    Mol Cell Biol. 2000 Jul;20(14):5119-28 PMID: 10866668
  4. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.
    Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13275-80 PMID: 11087869
  5. Surfing the p53 network.
    Nature. 2000 Nov 16;408(6810):307-10 PMID: 11099028
  6. Frequent activation of the beta-catenin-Tcf signaling pathway in nonfamilial colorectal carcinomas with microsatellite instability.
    Genes Chromosomes Cancer. 2001 Jan;30(1):32-7 PMID: 11107173
  7. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.
    Science. 1993 Apr 2;260(5104):85-8 PMID: 8465203
  8. Manipulation of transgenes by site-specific recombination: use of Cre recombinase.
    Methods Enzymol. 1993;225:890-900 PMID: 8231893
  9. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.
    Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50 PMID: 7708772
  10. Differential activation of peroxisome proliferator-activated receptors by eicosanoids.
    J Biol Chem. 1995 Oct 13;270(41):23975-83 PMID: 7592593
  11. Improved dicistronic mRNA expression vectors for efficient selection of transfectants highly expressing foreign genes.
    Biotechniques. 1996 Sep;21(3):398-402 PMID: 8879573
  12. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
    Science. 1997 Mar 21;275(5307):1784-7 PMID: 9065401
  13. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
    Science. 1997 Mar 21;275(5307):1787-90 PMID: 9065402
  14. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.
    Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7 PMID: 9113986
  15. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis.
    Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):681-6 PMID: 9435252
  16. A simplified system for generating recombinant adenoviruses.
    Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14 PMID: 9482916
  17. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
    Cancer Res. 1998 Mar 15;58(6):1130-4 PMID: 9515795
  18. Identification of c-MYC as a target of the APC pathway.
    Science. 1998 Sep 4;281(5382):1509-12 PMID: 9727977
  19. Differentiation and reversal of malignant changes in colon cancer through PPARgamma.
    Nat Med. 1998 Sep;4(9):1046-52 PMID: 9734398
  20. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.
    Nat Med. 1998 Sep;4(9):1053-7 PMID: 9734399
  21. Activators of the nuclear receptor PPARgamma enhance colon polyp formation.
    Nat Med. 1998 Sep;4(9):1058-61 PMID: 9734400
  22. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy.
    Clin Cancer Res. 1997 Dec;3(12 Pt 2):2696-702 PMID: 10068276
  23. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Nature. 1999 Apr 1;398(6726):422-6 PMID: 10201372
  24. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta.
    Genes Dev. 1999 Jun 15;13(12):1561-74 PMID: 10385625
  25. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.
    Nature. 1999 Oct 7;401(6753):616-20 PMID: 10524633
  26. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
    Mol Cell. 1999 Oct;4(4):597-609 PMID: 10549291
  27. Roles of PPARs in health and disease.
    Nature. 2000 May 25;405(6785):421-4 PMID: 10839530
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-02-27
Pages
2598-603
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC30184
Subset
IM
Grants
NCI NIH HHS · CA57345 · United States
NCI NIH HHS · P50 CA062924 · United States
NCI NIH HHS · CA62924 · United States
NCI NIH HHS · R37 CA057345 · United States
NCI NIH HHS · R01 CA057345 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]